Salona Global Medical Device Corp (LNDZF) Financial Statements (2023 and earlier)

Company Profile

Business Address 6160 INNOVATION WAY
CARLSBAD, CA 92009
State of Incorp. BC
Fiscal Year End February 28
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
11/30/2022
MRQ
2/28/2022
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,1398,057
Cash and cash equivalents3,1398,057
Receivables7,7976,596
Inventory, net of allowances, customer advances and progress billings8,5904,969
Inventory8,5904,969
Prepaid expense479413
Total current assets:20,00520,035
Noncurrent Assets
Operating lease, right-of-use asset7,8783,942
Property, plant and equipment3,0691,460
Long-term investments and receivables192 
Accounts and financing receivable, after allowance for credit loss192 
Intangible assets, net (including goodwill)21,95216,760
Goodwill12,5449,833
Intangible assets, net (excluding goodwill)9,4086,927
Prepaid expense  
Restricted cash and investments565485
Total noncurrent assets:33,65622,647
TOTAL ASSETS:53,66142,682
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,1393,679
Accounts payable3,7232,863
Accrued liabilities2,416817
Debt194174
Other liabilities2,066562
Other undisclosed current liabilities20,07218,740
Total current liabilities:28,47123,156
Noncurrent Liabilities
Long-term debt and lease obligation5874,616
Long-term debt, excluding current maturities587682
Liabilities, other than long-term debt6,027 
Operating lease, liability6,0273,934
Other undisclosed noncurrent liabilities 2,425(2,179)
Total noncurrent liabilities:9,0396,372
Total liabilities:37,51029,528
Equity
Equity, attributable to parent, including:16,15113,153
Common stock38,76738,046
Additional paid in capital8,0426,985
Accumulated other comprehensive income9681,006
Accumulated deficit(47,692)(33,365)
Other undisclosed equity, attributable to parent16,064480
Total equity:16,15113,153
TOTAL LIABILITIES AND EQUITY:53,66142,682

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
11/30/2022
TTM
2/28/2022
Revenues30,64018,312
Cost of revenue
(Cost of Goods and Services Sold)
(20,475)(12,350)
Gross profit:10,1665,962
Operating expenses(10,251)(5,728)
Operating income (loss):(85)234
Nonoperating income (expense)
(Gain (Loss), Foreign Currency Transaction, before Tax)
(13)16
Interest and debt expense(509)(373)
Loss from continuing operations before equity method investments, income taxes:(607)(122)
Other undisclosed loss from continuing operations before income taxes(13,871)(4,351)
Loss from continuing operations before income taxes:(14,478)(4,474)
Income tax benefit151102
Loss from continuing operations:(14,327)(4,372)
Loss before gain (loss) on sale of properties:(12,798)(4,372)
Net loss available to common stockholders, diluted:(14,327)(4,372)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
11/30/2022
TTM
2/28/2022
Net loss:(14,327)(4,372)
Comprehensive loss:(14,327)(4,372)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(38)63
Comprehensive loss, net of tax, attributable to parent:(14,365)(4,309)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: